Featured Network Trials

LCCC1028 Title: Neoadjuvant Pazopanib: A Phase II Study to Evaluate the Effect on Disease Response and Recurrence and to Establish Predictive Biomarkers of Drug Activity in Renal Cell Carcinoma

PI, Kim Rathmell    Affiliate Coordinator, Donna Rowe, Telephone:  (919) 966-2152 or EMAIL.

LCCC1011 Title: A Phase II Trial of Bendamustine in Combination with Rituximab in Older Patients with Previously Untreated Diffuse Large B-cell Lymphoma

PI, Steven Park    Affiliate Coordinator, Maureen Tynan, Telephone,   919-966-7359 or EMAIL.

LCCC1029 Title: Multi-Center, Randomized Placebo-Controlled Phase II Study of Regorafenib in Combination with FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) versus Placebo and FOLFIRI as Second Line Therapy in Patients with Metastatic Colorectal Cancer

PI, Bert O’Neil   Affiliate Coordinator, Maureen Tynan, Telephone,   919-966-7359 or EMAIL.

LCCC0921: Title A Multi-Center Open Label Phase II Study of Pazopanib In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer After Progression on First Line Therapy Containing Bevacizumab.

PI, Tom Stinchcombe   Affiliate Coordinator, Donna Rowe, Telephone:  (919) 966-2152 or EMAIL.

LCCC1025 Title: A Phase II Study Evaluating the Efficacy And Tolerability Of Everolimus (RAD001) In Combination With Trastuzumab And Vinorelbine In The Treatment Of Progressive HER2-Positive Breast Cancer Brain Metastases

PI, Carey Anders   Affiliate Coordinator, Donna Rowe, Telephone:  (919) 966-2152 or EMAIL.